These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17369277)

  • 1. Daptomycin-reversible rifampicin resistance in vancomycin-resistant Enterococcus faecium.
    Rand KH; Houck HJ; Silverman JA
    J Antimicrob Chemother; 2007 May; 59(5):1017-20. PubMed ID: 17369277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daptomycin synergy with rifampicin and ampicillin against vancomycin-resistant enterococci.
    Rand KH; Houck H
    J Antimicrob Chemother; 2004 Mar; 53(3):530-2. PubMed ID: 14963062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro synergy of daptomycin plus rifampin against Enterococcus faecium resistant to both linezolid and vancomycin.
    Pankey G; Ashcraft D; Patel N
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5166-8. PubMed ID: 16304195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives.
    Cafini F; Aguilar L; González N; Giménez MJ; Torrico M; Alou L; Sevillano D; Vallejo P; Prieto J
    J Antimicrob Chemother; 2007 Jun; 59(6):1185-9. PubMed ID: 17412725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibility of daptomycin and comparator agents tested against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: trend analysis of a 6-year period in US medical centers (2005-2010).
    Sader HS; Moet GJ; Farrell DJ; Jones RN
    Diagn Microbiol Infect Dis; 2011 Jul; 70(3):412-6. PubMed ID: 21546202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococci.
    Vouillamoz J; Moreillon P; Giddey M; Entenza JM
    J Antimicrob Chemother; 2006 Dec; 58(6):1208-14. PubMed ID: 17030515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
    Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
    Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of vancomycin-resistant Enterococcus faecium pyelonephritis with daptomycin during pregnancy.
    Shea K; Hilburger E; Baroco A; Oldfield E
    Ann Pharmacother; 2008 May; 42(5):722-5. PubMed ID: 18349306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model.
    Hall Snyder A; Werth BJ; Barber KE; Sakoulas G; Rybak MJ
    J Antimicrob Chemother; 2014 Aug; 69(8):2148-54. PubMed ID: 24777900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005).
    Sader HS; Watters AA; Fritsche TR; Jones RN
    BMC Infect Dis; 2007 Apr; 7():29. PubMed ID: 17442104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of daptomycin against Staphylococcus aureus and vancomycin-resistant Enterococcus faecium isolates associated with skin and soft tissue infections: first results from India.
    Dhawan B; Gadepalli R; Kapil A
    Diagn Microbiol Infect Dis; 2009 Oct; 65(2):196-8. PubMed ID: 19748433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rifampicin resistance and its fitness cost in Enterococcus faecium.
    Enne VI; Delsol AA; Roe JM; Bennett PM
    J Antimicrob Chemother; 2004 Feb; 53(2):203-7. PubMed ID: 14688044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of daptomycin non-susceptibility in colonizing vancomycin-resistant Enterococcus faecium isolates during daptomycin therapy.
    Lellek H; Franke GC; Ruckert C; Wolters M; Wolschke C; Christner M; Büttner H; Alawi M; Kröger N; Rohde H
    Int J Med Microbiol; 2015 Dec; 305(8):902-9. PubMed ID: 26454536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The first molecular analysis of clinical isolates of VanA-type vancomycin-resistant Enterococcus faecium strains in Mainland China.
    Zheng B; Tomita H; Xiao YH; Ike Y
    Lett Appl Microbiol; 2007 Sep; 45(3):307-12. PubMed ID: 17718844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-Lactam combinations with daptomycin provide synergy against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium.
    Smith JR; Barber KE; Raut A; Aboutaleb M; Sakoulas G; Rybak MJ
    J Antimicrob Chemother; 2015; 70(6):1738-43. PubMed ID: 25645208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vancomycin resistance among strains of Enterococcus faecium].
    Sacha P; Wieczorek P; Jakoniuk P
    Przegl Lek; 2008; 65(5):229-32. PubMed ID: 18853647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of vancomycin and daptomycin susceptibility in Staphylococcus aureus in reference to accessory gene regulator (agr) polymorphism and function.
    Rose WE; Rybak MJ; Tsuji BT; Kaatz GW; Sakoulas G
    J Antimicrob Chemother; 2007 Jun; 59(6):1190-3. PubMed ID: 17434881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical implications of vancomycin-resistant Enterococcus faecium (VRE) with VanD phenotype and vanA genotype.
    Song JH; Ko KS; Suh JY; Oh WS; Kang CI; Chung DR; Peck KR; Lee NY; Lee WG
    J Antimicrob Chemother; 2008 Apr; 61(4):838-44. PubMed ID: 18230690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nosocomial outbreak of vancomycin-resistant Enterococcus faecium in a paediatric unit at a Turkish university hospital.
    Ergani-Ozcan A; Naas T; Baysan BO; Ogunc D; Inan D; Colak D; Nordmann P
    J Antimicrob Chemother; 2008 May; 61(5):1033-9. PubMed ID: 18319236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of daptomycin resistance in a bone marrow transplant patient with vancomycin-resistant Enterococcus durans.
    Green MR; Anasetti C; Sandin RL; Rolfe NE; Greene JN
    J Oncol Pharm Pract; 2006 Sep; 12(3):179-81. PubMed ID: 17022872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.